SEC 13F Intelligence

Palo Alto Investors LP / DRNAUSD

Palo Alto Investors LP’s Dicerna Pharma Inc Com Usd0.0001 Position

Does Palo Alto Investors LP own Dicerna Pharma Inc Com Usd0.0001 (DRNAUSD)? Not currently — the last reported position was 855.7K shares worth $17M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$17M
Q3 2021
Shares
855.7K
% of Portfolio
+1.04%
Quarters Held
12
position exited

Position History DRNAUSD

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $7MQ2 ’19: $5MQ2 ’19Q3 ’19: $5MQ4 ’19: $7MQ4 ’19Q1 ’20: $6MQ2 ’20: $8MQ2 ’20Q3 ’20: $6MQ4 ’20: $7MQ4 ’20Q1 ’21: $9MQ2 ’21: $12MQ2 ’21Q3 ’21: $17Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021855.7K$17M+1.04%
Q2 2021332.7K$12M+0.68%
Q1 2021332.7K$9M+0.48%
Q4 2020331.8K$7M+0.38%
Q3 2020331.8K$6M+0.33%
Q2 2020331.8K$8M+0.51%
Q1 2020331.8K$6M+0.51%
Q4 2019331.8K$7M+0.40%
Q3 2019331.8K$5M+0.32%
Q2 2019331.8K$5M+0.25%
Q1 2019500.9K$7M+0.31%
Q4 2018500.9K$5M+0.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Palo Alto Investors LP’s full portfolio or all institutional holders of DRNAUSD.